SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wave Life Sciences announces GSK selection of siRNA program for transition

Wave Life Sciences said GSK selected its siRNA program to transition to GSK for further development.

WVE